“Treatment”的搜索结果，显示 311-320 项，共有 22850 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Ascorbic Acid And Chemotherapy For The Treatment Of Relapsed Or Refractory Lymphoma, CCUS, And Chronic Myelomonocytic Leukemia. Rochester, Minn., Mankato, Minn.

2. 胸腔外科- 临床试验- 妙佑医疗国际

   ... treatment in patients with treatment-naive ALK-positive advanced NSCLC. Patients will be randomized in a 1:1 ratio to receive either alectinib, 600 mg ...

3. 血液科- 临床试验- 妙佑医疗国际

   Tafasitamab, Lenalidomide And Venetoclax For The Treatment Of Relapsed Or Refractory Mantle Cell Lymphoma. Rochester, Minn. The purpose of this study is to ...

4. 血液科- 临床试验- 妙佑医疗国际

   ... treatment, in order to classify patients into post-consolidation treatment groups. On the second part of this study, patients will receive the remainder of ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... treatment of R/R Multiple Myeloma (MM). This study includes 2 parts ... treatment, in order to classify patients into post-consolidation treatment groups.

6. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, and ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... treatment, while rates of disease control during Induction have not improved in recent COG trials. The current phase 3 trial seeks to improve the event-free ...

8. 传染性软疣- Diagnosis & treatment - Mayo Clinic

   如果是重度或分布较广，医务人员可能将您转诊给皮肤病专家（皮肤科医生），以讨论去除肿块的方案。 治疗可能涉及以下一种或 ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... treatment, while rates of disease control during Induction have not improved in recent COG trials. The current phase 3 trial seeks to improve the event-free ...

10. 血液科- 临床试验- 妙佑医疗国际

    ... treatment of R/R Multiple Myeloma (MM). This study includes 2 parts ... treatment, in order to classify patients into post-consolidation treatment groups.